IVUS-OCT市场报告：趋势、预测和竞争分析（至2031年）

由于医院和门诊手术中心市场的巨大机会，全球血管内超音波-光学相干断层扫描（IVUS-OCT）市场前景看好。预计2025年至2031年，全球IVUS-OCT市场将以7.1%的复合年增长率成长。推动该市场成长的关键因素包括心血管疾病盛行率的上升、新兴市场医疗基础设施的不断改善以及对先进医学影像技术投资的持续成长。

• 根据 Lucintel 的预测，36 毫米/秒的拉拔速度预计将在预测期内呈现最高的成长率。
• 从应用角度来看，医院预计将呈现更高的成长率。
• 从区域来看，预计亚太地区在预测期内将达到最高的成长率。

IVUS-OCT市场的新趋势

血管内超音波-光同调断层扫瞄（IVUS-OCT）市场正受益于技术进步、临床应用日益广泛以及对微创手术的日益重视而迅速发展。随着医疗机构寻求更精准的诊断工具和更好的病患治疗效果，血管内超音波（IVUS）与光学相干断层扫描（OCT）的融合正在改变心血管影像。这些创新不仅提高了诊断准确性，也提升了手术效率和安全性。心血管疾病盛行率的上升以及对先进影像解决方案的需求进一步推动了市场成长。对于希望挖掘市场潜力并改善患者照护的相关人员，了解这些新兴趋势至关重要。

• 技术整合：血管内超音波（IVUS）和光学相干断层扫描（OCT）技术的融合正在催生出能够提供全面血管资讯的混合成像系统。这些整合设备可提供具有深度和组织特征的高解析度影像，从而实现更精准的诊断和治疗方案製定。这些影像方式的无缝结合提高了手术精确度，缩短了手术时间，并改善了患者的预后。随着技术的进步，这些混合系统正变得越来越易于使用且经济高效，从而促进了其在临床实践中的广泛应用。
• 小型化与便携性：设备设计的创新使得血管内超音波-光学相干断层扫描（IVUS-OCT）系统体积更小、更便携。这些紧凑型设备提高了手术操作的灵活性，尤其是在复杂区域或难以触及的血管区域。便携性使其能够在床边或门诊使用，从而减少住院时间和相关费用。小型化还使其能够与其他诊断工具集成，扩大微创介入治疗的范围，并促进市场扩张，尤其是在资源有限的地区。
• 人工智慧与数据分析：人工智慧和机器学习演算法的引入正在革新血管内超音波-光学相干断层扫描（IVUS-OCT）市场中的影像分析。这些技术能够辅助临床医生进行即时影像解读、病灶定性和风险评估，从而实现更准确、更一致的诊断。人工智慧驱动的分析还能促进大规模资料管理，实现个人化治疗方案和预测建模。这一趋势有助于提升临床决策水平，降低对操作者的依赖性，提高工作流程效率，最终改善患者预后。
• 临床应用日益广泛：人们对血管内超音波-光学相干断层扫描（IVUS-OCT）优势的认识不断提高，推动了心臟病专家和介入放射科医生对该技术的采用。临床研究表明，IVUS-OCT 可提高诊断准确性和手术成功率，这鼓励医疗机构将这些技术纳入日常诊疗实践。此外，不断完善的医保报销政策和培训计画也促进了其更广泛的应用。随着临床信心的增强，预计随着更多医院和诊所将 IVUS-OCT 纳入心血管诊疗通讯协定，市场将持续成长。
• 监管核准和报销政策：不断变化的监管环境和报销框架对市场动态有显着影响。 FDA和EMA等监管机构对先进的血管内超音波-光学相干断层扫描（IVUS-OCT）设备的核准，有助于其进入市场并广泛应用。同时，优惠的报销政策奖励医疗机构使用这些技术，使相关诊疗流程更具经济可行性。清晰的监管路径和报销策略对于促进创新、鼓励製造商开发新解决方案以及确保先进诊断成像技术的广泛应用至关重要。

总而言之，这些新兴趋势正透过提昇技术能力、改善临床工作流程和扩大应用范围，共同重塑血管内超音波-光学相干断层扫描（IVUS-OCT）市场。先进成像技术、人工智慧和携带式设备的整合正在推动创新，而有利的法规环境则促进了其广泛应用。这些发展有望转化为更高的诊断准确性、手术安全性和患者预后，最终改变心血管影像和介入治疗的实践。

IVUS-OCT市场近期趋势

在技​​术创新、临床应用日益广泛以及心血管诊断应用不断拓展的推动下，血管内超音波-光学相干断层扫描（IVUS-OCT）市场正经历显着的进步。这些进步正在塑造血管内成像的未来，显着提升其准确性、安全性和诊断能力。随着医疗机构寻求更有效的早期检测和治疗方案製定工具，该市场有望迎来快速成长。近期的发展趋势集中在先进成像模式的整合、设备易用性的提升以及地理部署的扩展。这些因素共同影响市场动态、竞争策略和患者预后，使IVUS-OCT市场成为心血管医学领域创新发展的关键方向。

• 技术整合：将 IVUS 和 OCT 整合到混合系统中，可提高影像准确性和诊断信心，从而改善临床决策和患者预后。
• 设备小型化：设备小型化的进步使得设备更容易在复杂的血管内进行操作，提高了手术的成功率，并扩大了设备在较小血管中的应用。
• 监管核准：新型 IVUS-OCT 设备的持续核准正在加速市场渗透，鼓励医疗保健提供者更多采用和创新。
• 不断扩大的临床证据：越来越多的临床研究表明，IVUS-OCT 在斑块表征和支架优化方面具有有效性，这提高了临床医生的信心和使用率。
• 区域市场成长：亚太和拉丁美洲等新兴市场由于心血管疾病的日益普遍和医疗保健基础设施的发展，其采用率正在不断提高。

这些发展正透过提升设备功能、拓展临床应用范围和扩大地理覆盖面，推动整体市场成长。尤其值得一提的是，先进影像技术的整合和监管支援产生了显着影响，为血管内超音波-光学相干断层扫描（IVUS-OCT）市场的持续扩张和创新奠定了基础。

目录

第一章执行摘要

第二章 市场概览

• 背景和分类
• 供应链

第三章：市场趋势与预测分析

• 宏观经济趋势与预测
• 产业驱动因素与挑战
• PESTLE分析
• 专利分析
• 法规环境

第四章 全球血管内超音波-光学相干断层扫描市场（按类型划分）

• 吸引力分析：按类型
• 拉动速度 36 毫米/秒
• 拉速 25 毫米/秒
• 拉速 10 毫米/秒
• 其他的

第五章 全球血管内超音波-光学相干断层扫描（IVUS-OCT）市场依应用领域划分

• 吸引力分析：依目的
• 医院
• 门诊手术中心
• 其他的

第六章 区域分析

第七章 北美IVUS-OCT市场

• 北美IVUS-OCT市场按类型划分
• 北美IVUS-OCT市场按应用划分
• 美国血管内超音波-光学相干断层扫描市场
• 墨西哥的IVUS-OCT市场
• 加拿大血管内超音波-光学相干断层扫描市场

第八章：欧洲血管内超音波-光学相干断层扫描市场

• 欧洲血管内超音波-光学相干断层扫描（IVUS-OCT）市场按类型划分
• 欧洲血管内超音波-光学相干断层扫描（IVUS-OCT）市场依应用领域划分
• 德国 IVUS-OCT 市场
• 法国血管内超音波-光学相干断层扫描市场
• 西班牙 IVUS-OCT 市场
• 义大利 IVUS-OCT 市场
• 英国血管内超音波-光学相干断层扫描市场

9. 亚太地区血管内超音波-光学相干断层扫描市场

• 亚太地区血管内超音波-光学相干断层扫描（IVUS-OCT）市场按类型划分
• 按应用分類的亚太地区血管内超音波-光学相干断层扫描（IVUS-OCT）市场
• 日本的血管内超音波-光学相干断层扫描（IVUS-OCT）市场
• 印度 IVUS-OCT 市场
• 中国的血管内超音波-光学相干断层扫描市场
• 韩国IVUS-OCT市场
• 印尼的IVUS-OCT市场

10. 世界其他地区 (ROW) IVUS-OCT 市场

• 按类型分類的 ROW IVUS-OCT 市场
• 按应用分類的 ROW IVUS-OCT 市场
• 中东IVUS-OCT市场
• 南美洲IVUS-OCT市场
• 非洲血管内超音波-光学相干断层扫描市场

第十一章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析
• 市占率分析

第十二章：机会与策略分析

• 价值链分析
• 成长机会分析
• 全球血管内超音波-光学相干断层扫描（IVUS-OCT）市场新兴趋势
• 战略分析

第十三章：价值链中主要企业的概况

• 竞争分析：概述
• Terumo
• Conavi Medical
• Grand Pharmaceutical
• Horimed Care
• Panovision Medical

第十四章附录

The future of the global IVUS-OCT market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global IVUS-OCT market is expected to grow with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing prevalence of cardiovascular diseases, the growing healthcare infrastructure in emerging market, and the rising investment in advanced medical imaging technology.

• Lucintel forecasts that, within the type category, 36 mm/s retraction speed is expected to witness the highest growth over the forecast period.
• Within the application category, hospital is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the IVUS-OCT Market

The IVUS-OCT market is experiencing rapid evolution driven by technological advancements, increasing clinical adoption, and a growing emphasis on minimally invasive procedures. As healthcare providers seek more precise diagnostic tools and better patient outcomes, the integration of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) is transforming cardiovascular imaging. These innovations are not only enhancing diagnostic accuracy but also improving procedural efficiency and safety. The markets growth is further fueled by rising cardiovascular disease prevalence and the need for advanced imaging solutions. Understanding these emerging trends is crucial for stakeholders aiming to capitalize on the markets potential and improve patient care.

• Technological Integration: The convergence of IVUS and OCT technologies is creating hybrid imaging systems that offer comprehensive vascular insights. These integrated devices provide high-resolution images with depth and tissue characterization, enabling more accurate diagnosis and treatment planning. The seamless combination of these modalities enhances procedural precision, reduces procedure time, and improves patient outcomes. As technology advances, these hybrid systems are becoming more user-friendly and cost-effective, driving wider adoption in clinical settings.
• Miniaturization and Portability: Innovations in device design are leading to smaller, more portable IVUS-OCT systems. These compact devices facilitate easier handling during procedures, especially in complex or hard-to-reach vascular regions. Portability allows for bedside or outpatient use, reducing hospital stays and associated costs. Miniaturization also enables integration with other diagnostic tools, broadening the scope of minimally invasive interventions and expanding market reach, particularly in resource-limited settings.
• Artificial Intelligence and Data Analytics: The incorporation of AI and machine learning algorithms is revolutionizing image analysis within the IVUS-OCT market. These technologies assist clinicians in real-time interpretation, lesion characterization, and risk assessment, leading to more accurate and consistent diagnoses. AI-driven analytics also facilitate large-scale data management, enabling personalized treatment plans and predictive modeling. This trend enhances clinical decision-making, reduces operator dependency, and accelerates workflow efficiency, ultimately improving patient outcomes.
• Growing Clinical Adoption: Increasing awareness of IVUS-OCT benefits is driving adoption among cardiologists and interventional radiologists. Clinical studies demonstrating improved diagnostic accuracy and procedural success are encouraging healthcare providers to incorporate these technologies into routine practice. Additionally, expanding reimbursement policies and training programs are supporting wider utilization. As clinical confidence grows, the market is expected to see sustained growth, with more hospitals and clinics integrating IVUS-OCT into their cardiovascular care protocols.
• Regulatory Approvals and Reimbursement Policies: Evolving regulatory landscapes and reimbursement frameworks are significantly impacting market dynamics. Approval of advanced IVUS-OCT devices by authorities like the FDA and EMA facilitates market entry and adoption. Simultaneously, favorable reimbursement policies incentivize healthcare providers to utilize these technologies, making procedures more financially viable. Clear regulatory pathways and reimbursement strategies are essential for fostering innovation, encouraging manufacturers to develop new solutions, and ensuring broader access to advanced imaging modalities.

In summary, these emerging trends are collectively reshaping the IVUS-OCT market by enhancing technological capabilities, improving clinical workflows, and expanding access. The integration of advanced imaging, AI, and portable devices is driving innovation, while supportive regulatory and reimbursement environments are facilitating widespread adoption. These developments are poised to improve diagnostic accuracy, procedural safety, and patient outcomes, ultimately transforming cardiovascular imaging and intervention practices.

Recent Developments in the IVUS-OCT Market

The IVUS-OCT Market has experienced significant advancements driven by technological innovations, increasing clinical adoption, and expanding applications in cardiovascular diagnostics. These developments are shaping the future landscape of intravascular imaging, offering enhanced precision, safety, and diagnostic capabilities. As healthcare providers seek more effective tools for early detection and treatment planning, the market is poised for rapid growth. Recent trends reflect a focus on integrating advanced imaging modalities, improving device usability, and expanding regional presence. These factors collectively influence market dynamics, competitive strategies, and patient outcomes, making the IVUS-OCT Market a critical area of innovation in cardiovascular medicine.

• Technological Integration: Combining IVUS and OCT into hybrid systems has improved imaging accuracy and diagnostic confidence, leading to better clinical decision-making and patient outcomes.
• Miniaturization of Devices: Advances in device miniaturization have enabled easier navigation through complex vasculature, increasing procedural success rates and expanding use in smaller vessels.
• Regulatory Approvals: Recent approvals of new IVUS-OCT devices have accelerated market penetration, encouraging adoption among healthcare providers and fostering innovation.
• Growing Clinical Evidence: Increasing clinical studies demonstrating the efficacy of IVUS-OCT in plaque characterization and stent optimization have boosted clinician confidence and usage.
• Regional Market Expansion: Emerging markets in Asia-Pacific and Latin America are witnessing increased adoption due to rising cardiovascular disease prevalence and healthcare infrastructure development.

These developments are collectively driving market growth by enhancing device capabilities, expanding clinical applications, and broadening geographic reach. The integration of advanced imaging technologies and regulatory support are particularly influential, positioning the IVUS-OCT Market for sustained expansion and innovation.

Strategic Growth Opportunities in the IVUS-OCT Market

The IVUS-OCT market is experiencing rapid evolution driven by technological advancements and increasing demand for precise cardiovascular diagnostics. As healthcare providers seek minimally invasive solutions with higher accuracy, the integration of IVUS and OCT technologies offers significant growth potential across various applications. These developments are transforming diagnostic and treatment paradigms, enabling better patient outcomes and more efficient procedures. Key growth opportunities are emerging in diverse sectors, reflecting the expanding scope and adoption of IVUS-OCT systems. Understanding these opportunities is crucial for stakeholders aiming to capitalize on market trends and enhance their competitive edge in this dynamic landscape.

• Cardiology Imaging: The integration of IVUS and OCT provides detailed visualization of arterial plaques, improving diagnosis and treatment planning for coronary artery disease. This leads to more targeted interventions, reducing complications and improving patient outcomes.
• Interventional Cardiology: IVUS-OCT systems offer real-time imaging during interventions such as stent placement, ensuring precise deployment. This reduces procedural risks and enhances the success rate of minimally invasive treatments.
• Oncology Imaging: The high-resolution imaging capabilities of IVUS-OCT are increasingly used to accurately define tumor boundaries, aiding in precise biopsies and surgical excisions, thus improving treatment efficacy.
• Peripheral Vascular Disease Management: The technology enables detailed visualization of peripheral vessels, facilitating early detection of blockages and vessel wall abnormalities, which supports timely intervention and better management of peripheral vascular conditions.
• Research and Development: Continuous advancements in IVUS-OCT systems foster new applications and improve existing functionalities. This drives innovation in cardiovascular research, leading to the development of more sophisticated diagnostic tools.

In summary, these growth opportunities are significantly impacting the IVUS-OCT market by expanding its application scope, improving diagnostic accuracy, and enhancing procedural outcomes. As these developments continue, the market is poised for substantial growth, driven by technological innovation and increasing clinical adoption across diverse medical fields.

IVUS-OCT Market Driver and Challenges

The IVUS-OCT Market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in imaging technology, increasing demand for minimally invasive procedures, and evolving regulatory standards are key drivers. Economic factors such as rising healthcare expenditure and the growing prevalence of cardiovascular diseases further propel market expansion. However, the market also faces challenges, including high device costs, regulatory hurdles, and the need for specialized training. These factors collectively impact market dynamics, influencing innovation, adoption rates, and overall competitiveness. Understanding these drivers and challenges is essential for stakeholders aiming to capitalize on emerging opportunities and navigate potential obstacles effectively.

The factors responsible for driving the IVUS-OCT Market include:

• Technological Advancements: The continuous development of high-resolution imaging systems enhances diagnostic accuracy and procedural outcomes. Innovations like hybrid IVUS-OCT devices provide comprehensive vessel assessment, improving clinical decision-making. These technological improvements attract healthcare providers seeking precise, minimally invasive options, thereby expanding market adoption. As technology evolves, manufacturers can offer more sophisticated, user-friendly devices, fostering market growth and encouraging research and development investments.
• Rising Prevalence of Cardiovascular Diseases: The increasing incidence of coronary artery disease and other cardiovascular conditions globally drives demand for advanced imaging techniques. Early and accurate diagnosis facilitated by IVUS-OCT enables better treatment planning, reducing complications and improving patient outcomes. This growing disease burden compels healthcare systems to adopt innovative diagnostic tools, fueling market expansion and encouraging manufacturers to develop tailored solutions.
• Favorable Reimbursement Policies: Improved reimbursement frameworks for minimally invasive imaging procedures incentivize healthcare providers to adopt IVUS-OCT technology. Reimbursement coverage reduces out-of-pocket expenses for patients and hospitals, promoting wider utilization. Supportive policies also attract investments from medical device companies, accelerating product development and market penetration, especially in emerging markets where reimbursement schemes are evolving.
• Increasing Healthcare Expenditure: Rising healthcare budgets across developed and developing countries facilitate the adoption of advanced diagnostic tools like IVUS-OCT. Higher spending enables hospitals and clinics to invest in cutting-edge imaging equipment, improving diagnostic capabilities. This financial support encourages innovation and helps expand access to these technologies, ultimately driving market growth and fostering competitive advancements.
• Growing Awareness and Adoption of Minimally Invasive Procedures: The shift towards less invasive diagnostic and therapeutic options increases demand for IVUS-OCT systems. Patients and clinicians prefer procedures with reduced recovery times and lower complication risks. This trend promotes the integration of IVUS-OCT into routine clinical practice, expanding its market share and encouraging manufacturers to develop more accessible and efficient devices.

The challenges facing this Market include:

• High Device Costs: The advanced technology involved in IVUS-OCT systems results in high manufacturing and procurement costs. These expenses can limit adoption, especially in cost-sensitive markets or smaller healthcare facilities. Additionally, the need for regular maintenance and specialized training adds to the overall expenditure, potentially hindering widespread implementation and slowing market growth.
• Regulatory Hurdles: Stringent regulatory approval processes for medical devices can delay product launches and increase development costs. Navigating diverse regulatory landscapes across regions requires significant resources and expertise. These hurdles can impede timely market entry, restrict innovation, and create barriers for new entrants, affecting overall market competitiveness.
• Need for Specialized Training and Expertise: Effective utilization of IVUS-OCT technology demands specialized skills and training for healthcare professionals. The lack of adequately trained personnel can limit the technology's adoption and optimal use. Developing comprehensive training programs involves time and investment, which may slow down market expansion, especially in regions with limited educational infrastructure.

In summary, the IVUS-OCT Market is driven by technological innovations, increasing cardiovascular disease prevalence, favorable reimbursement policies, rising healthcare expenditure, and a shift towards minimally invasive procedures. However, high device costs, regulatory challenges, and the need for specialized training pose significant obstacles. These factors collectively influence market growth, requiring stakeholders to strategize effectively to leverage opportunities while addressing challenges. Overall, the markets future depends on balancing technological progress with regulatory and economic considerations to ensure broader access and sustained innovation.

List of IVUS-OCT Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies IVUS-OCT companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the IVUS-OCT companies profiled in this report include-

• Terumo
• Conavi Medical
• Grand Pharmaceutical
• Horimed Care
• Panovision Medical

IVUS-OCT Market by Segment

The study includes a forecast for the global IVUS-OCT market by type, application, and region.

IVUS-OCT Market by Type [Value from 2019 to 2031]:

• 36 mm/s Retraction Speed
• 25 mm/s Retraction Speed
• 10 mm/s Retraction Speed
• Others

IVUS-OCT Market by Application [Value from 2019 to 2031]:

• Hospital
• Ambulatory Surgery Center
• Others

IVUS-OCT Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the IVUS-OCT Market

The IVUS-OCT market has experienced significant advancements driven by technological innovations, increasing adoption in clinical settings, and expanding applications in cardiovascular diagnostics. As healthcare systems evolve and the demand for precise imaging grows, key players are investing in research and development to enhance device capabilities. Regulatory approvals and strategic collaborations are also shaping market dynamics across major regions. The United States, China, Germany, India, and Japan are at the forefront of these developments, each contributing unique trends based on their healthcare infrastructure, technological adoption, and market needs.

• United States: The US market has seen rapid adoption of IVUS-OCT technology, driven by high healthcare expenditure and a focus on minimally invasive procedures. Leading companies are launching advanced imaging systems with improved resolution and integration with AI for better diagnostics. Regulatory bodies like the FDA are approving innovative devices, boosting market growth. Hospitals and cardiology centers increasingly incorporate IVUS-OCT for complex coronary interventions, expanding clinical applications.
• China: China's IVUS-OCT market is expanding due to rising cardiovascular disease prevalence and government initiatives to modernize healthcare infrastructure. Local manufacturers are developing cost-effective devices to meet growing demand. The adoption of IVUS-OCT is supported by increasing awareness among clinicians and investments in research. Collaborations with international firms are facilitating technology transfer, and regulatory reforms are streamlining device approvals.
• Germany: Germany's market is characterized by high adoption of advanced imaging technologies in cardiology. The focus is on integrating IVUS-OCT with other diagnostic tools for comprehensive cardiovascular assessment. The country emphasizes clinical research and innovation, with several hospitals conducting trials to validate new devices. Regulatory standards are stringent, ensuring high-quality device deployment, which sustains market growth.
• India: The Indian IVUS-OCT market is witnessing rapid growth due to increasing cardiovascular disease burden and expanding healthcare access. Local companies are introducing affordable, portable imaging solutions suitable for diverse clinical settings. There is a rising trend of adopting IVUS-OCT in rural and semi-urban areas, supported by government health initiatives. Training programs and awareness campaigns are boosting clinician adoption of this technology.
• Japan: Japan's market is driven by an aging population and a high prevalence of cardiovascular conditions. The focus is on precision diagnostics and minimally invasive procedures. Japanese firms are investing in R&D to develop high-resolution, compact IVUS-OCT devices. The healthcare system's emphasis on early detection and advanced treatment options is fostering market expansion, with collaborations between academia and industry enhancing technological progress.

Features of the Global IVUS-OCT Market

• Market Size Estimates: IVUS-OCT market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: IVUS-OCT market size by type, application, and region in terms of value ($B).
• Regional Analysis: IVUS-OCT market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different type, application, and regions for the IVUS-OCT market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the IVUS-OCT market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the IVUS-OCT market by type (36 mm/s retraction speed, 25 mm/s retraction speed, 10 mm/s retraction speed, and others), application (hospital, ambulatory surgery center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global IVUS-OCT Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 36 Mm/S Retraction Speed : Trends and Forecast (2019-2031)
• 4.4 25 Mm/S Retraction Speed : Trends and Forecast (2019-2031)
• 4.5 10 Mm/S Retraction Speed : Trends and Forecast (2019-2031)
• 4.6 Others : Trends and Forecast (2019-2031)

5. Global IVUS-OCT Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Hospital : Trends and Forecast (2019-2031)
• 5.4 Ambulatory Surgery Center : Trends and Forecast (2019-2031)
• 5.5 Others : Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global IVUS-OCT Market by Region

7. North American IVUS-OCT Market

• 7.1 Overview
• 7.2 North American IVUS-OCT Market by Type
• 7.3 North American IVUS-OCT Market by Application
• 7.4 The United States IVUS-OCT Market
• 7.5 Canadian IVUS-OCT Market
• 7.6 Mexican IVUS-OCT Market

8. European IVUS-OCT Market

• 8.1 Overview
• 8.2 European IVUS-OCT Market by Type
• 8.3 European IVUS-OCT Market by Application
• 8.4 German IVUS-OCT Market
• 8.5 French IVUS-OCT Market
• 8.6 Italian IVUS-OCT Market
• 8.7 Spanish IVUS-OCT Market
• 8.8 The United Kingdom IVUS-OCT Market

9. APAC IVUS-OCT Market

• 9.1 Overview
• 9.2 APAC IVUS-OCT Market by Type
• 9.3 APAC IVUS-OCT Market by Application
• 9.4 Chinese IVUS-OCT Market
• 9.5 Indian IVUS-OCT Market
• 9.6 Japanese IVUS-OCT Market
• 9.7 South Korean IVUS-OCT Market
• 9.8 Indonesian IVUS-OCT Market

10. ROW IVUS-OCT Market

• 10.1 Overview
• 10.2 ROW IVUS-OCT Market by Type
• 10.3 ROW IVUS-OCT Market by Application
• 10.4 Middle Eastern IVUS-OCT Market
• 10.5 South American IVUS-OCT Market
• 10.6 African IVUS-OCT Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunity by Type
  • 12.2.2 Growth Opportunity by Application
• 12.3 Emerging Trends in the Global IVUS-OCT Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis Overview
• 13.2 Terumo
  • Company Overview
  • IVUS-OCT Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Conavi Medical
  • Company Overview
  • IVUS-OCT Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Grand Pharmaceutical
  • Company Overview
  • IVUS-OCT Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Horimed Care
  • Company Overview
  • IVUS-OCT Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Panovision Medical
  • Company Overview
  • IVUS-OCT Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us